• By ICR Secretariat
  • Posted Wednesday, August 2, 2023

Cannabinoid company expands into oncology


Oxford Cannabinoid Technologies Holdings (OCTP) – the company developing prescription cannabinoid medicines – is expanding its research and development plans into oncology. The decision comes after it identified a potential first in class immunotherapy agent for solid tumour treatment.